Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia · Delayed Price · Currency is SAR 32.60
+0.40 (1.24%)
Jul 2, 2026, 3:19 PM AST
TADAWUL:4009 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, TADAWUL:4009 stock has a consensus rating of "Hold" and an average price target of SAR 57.80. The average 1-year stock price forecast is 77.30% higher than the current stock price, while the lowest is SAR 36.00 (+10.43%) and the highest is SAR 80.20 (+146.01%).
Price Target: SAR 57.80 (+77.30%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for TADAWUL:4009 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 6 | 6 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
3.34B
from 3.10B
Increased by 7.59%
Revenue Next Year
3.62B
from 3.34B
Increased by 8.54%
EPS This Year
1.60
from 3.28
Decreased by -51.22%
EPS Next Year
2.15
from 1.60
Increased by 34.06%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.4B | ||
| Avg | 3.3B | ||
| Low | 3.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.0% | ||
| Avg | 7.6% | ||
| Low | 7.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.74 | ||
| Avg | 1.60 | ||
| Low | 1.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -47.0% | ||
| Avg | -51.2% | ||
| Low | -55.5% |